European Disease Progression Monitor: Edition 5

European Disease Progression Monitor: Edition 5

COVID-19 EU progression monitor

lockdown exit strategies in EU

lockdown transition plan

COVID-19 death rate EU

tracking the pandemic

control phase

French data

U.K. numbers have stabilised

Overview of treatments

Disclaimer

For more information, please visit lek.com/covid19 or fill out this form to get in touch.

Other editions in this series:
European Disease progression monitor: Edition 4

Related Insights

Executive Insights

Life Sciences & Pharma

How Pharma Companies Are Driving the Next Wave of Revenue Growth

June 25, 2025

Executive Insights

Life Sciences & Pharma

Advanced In Vitro Models: Opportunities and Challenges for US Drug Development

May 7, 2025

Organization & Performance

Procurement Excellence as Competitive Advantage: Lowering Costs to Elevate Products

May 6, 2025

Life Sciences & Pharma

Optimizing Biopharma Operations for Strategic Growth

May 6, 2025

Executive Insights

Life Sciences & Pharma

Launching Novel CDx for Oncology: 7 Strategies for Biopharma Companies

April 17, 2025

Video / Webinar

Artificial Intelligence

Look Forward 2025: Proving AI’s Value

January 16, 2025